Bruker Mbioseq Trademark Application Published for Opposition
Summary
The USPTO has published the trademark application for 'Bruker Mbioseq' for opposition. The application covers reagents, assays, and software related to medical diagnostics, molecular biology, and laboratory apparatus. The filing date was November 18, 2025.
What changed
The United States Patent and Trademark Office (USPTO) has published a trademark application (TM79440055) for the mark 'Bruker Mbioseq' for opposition. The application seeks protection for a range of goods and services including reagents and assays for medical and diagnostic purposes, chemical reagents for molecular biology, downloadable software for laboratory apparatus and bioinformatics analysis, laboratory apparatus (other than for medical use), medical instruments for diagnostic tests and molecular diagnostics, and natural science/technical services for identifying and characterizing substances.
This publication initiates a period where third parties can oppose the registration of this trademark. While this is primarily an intellectual property matter, the scope of the application touches upon pharmaceutical and biotechnology sectors, indicating potential market positioning for Bruker in areas such as medical diagnostics, genetic testing, and laboratory research. Compliance officers in related fields should be aware of this publication as it pertains to the branding and market entry of new products and services in the life sciences.
Source document (simplified)
← USPTO Trademark Applications
BRUKER MBIOSEQ
Published for Opposition TM79440055 Kind: published Mar 26, 2026
Abstract
Reagents and assays for medical purposes; diagnostic reagents and assays for medical use; chemical reagents for molecular biology, for medical or veterinary use; chemical reagents and assays for use in medical and veterinary testing, for detecting genetic mutations.; Downloadable and recorded computer software for laboratory apparatus, other than for medical use; downloadable and recorded computer software for processing, evaluating and displaying measurement data from a laboratory apparatus; downloadable and recorded software for bioinformatics analysis, genomic data interpretation, and drug resistance profiling; laboratory apparatus, other than for medical use; laboratory apparatus, other than for medical use, for the collection, sequencing, application, and transfer of microbial and non-microbial preparations.; Medical instruments; instruments for carrying-out diagnostic tests for medical purposes; laboratory instruments for medical use; laboratory instruments for medical use for collection, sequencing, application, and transfer of microbial and non-microbial preparations; medical instruments for use in molecular diagnostics.; Reagents and assays for research purposes; diagnostic reagents and assays for scientific use; chemical reagents and assays for molecular biology, other than for medical or veterinary use; chemical reagents and assays for use in genetic research, for detecting genetic mutations.; Natural science and technical services for identifying and characterizing substances, in particular measurement of biological samples and evaluating measurement data of biological samples; design and development of computer software for use in molecular diagnostics.
Filing Date
2025-11-18
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.